OrthoSensor, a leader in intelligent orthopaedics, and Zimmer Holdings, Inc., a global leader in musculoskeletal health, announced today that they have entered into a co-marketing partnership which will marry Zimmer knee systems with OrthoSensor’s VERASENSE Sensor-Assisted Technology.
“While we currently lead the industry in Patient Reported Outcomes (PROMs) with our NexGen Knee, we know that component placement and soft-tissue balancing are critical to patient satisfaction and implant longevity,” said Jeff McCaulley, Zimmer Reconstructive President. “As such, Zimmer is committed to offering the widest array of intelligent instrumentation to assist surgeons. Our collaboration with OrthoSensor, and the ability to leverage real data in soft tissue balancing with VERASENSE, should allow for even more satisfied patients.”
Research has shown that soft tissue balance may aid in the reduction of pain, wear, and implant loosening – while also improving how the knee replacement feels to the patient.1 The OrthoSensor VERASENSE Knee System provides surgeons with real-time data that enables evidence-based intraoperative decisions regarding component position, limb alignment and soft-tissue releases to achieve soft tissue balance and stability through a full range of motion.
“VERASENSE gives orthopaedic surgeons actionable data during their procedures that helps quantify and verify implant positioning and knee balance,” said Jay Pierce, CEO and President of OrthoSensor. “This agreement allows development of VERASENSE technology that will be used initially with the Zimmer NexGen system, allowing more surgeons to benefit from the data provided to them by VERASENSE. We welcome the Zimmer knee portfolio into the VERASENSE technology platform and look forward to working with Zimmer to improve patient outcomes and satisfaction.”